In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and ...

However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies ...

Weight loss drugs like Ozempic were associated with a lower risk of suicidal thoughts in teens with obesity, a new study found.

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

WeightWatchers (NASDAQ: WW) (“WeightWatchers,” “WW,” or the “Company”) announced today the addition of compounded semaglutide into its offering, broadening eligible members’ access to clinical weight ...

That’s where injectables like Ozempic come in. GLP-1 supplement makers claim that their products work similarly to weight loss injections, but without the poke, using natural plant compounds ...

Tirzepatide, a dual GIP and GLP-1 receptor agonist, has gained widespread recognition for its effectiveness in promoting substantial weight loss by enhancing metabolic functions and controlling ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months before he actually filled the prescription. And even when he got the drug, he waited a month before using it.

Now, research finds this scenario is more likely if the patient is taking popular new weight-loss meds such as ... have suggested that people taking GLP-1 medications might face a higher odds ...